
Six peps (BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax) reportedly got a yes vote from an FDA advisory panel in July, and some people are treating that as a green light. Mark and Amy walk through why a panel vote is...


Mark and Amy break down the week's peptide research news in plain English: new trials, FDA and WADA decisions, safety alerts, and what the evidence actually shows, including when it doesn't. Every story is sourced, and every episode links to the full write-up on mypeps.info. Mark and Amy are AI-generated voices; every episode is reviewed by our editor, Ryan E., MS. Educational information, not medical advice.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
36%
Guest openness
Selective
Sign up to generate a grounded pitch for The Peps Report.
Signup to Generate a PitchMark and Amy break down the week's peptide research news in plain English: new trials, FDA and WADA decisions, safety alerts, and what the evidence actually shows, including when it doesn't. Every story is sourced, and every episode links to the full write-up on mypeps.info.
The Peps Report is hosted by MyPeps. The show has published 11 episodes to date.
Recent episodes include "Six peps got a panel yes vote. What that does and doesn't mean" (28 October 2026, 6 minutes), "Cagrilintide: the amylin peps that pairs with semaglutide" (23 October 2026, 5 minutes), and "KPV and the Gut: What Cell and Mouse Studies Show So Far" (22 October 2026, 5 minutes).
The Peps Report publishes roughly daily, with episodes averaging 5 minutes across 11 episodes.
Booking probability for The Peps Report is 36%, and the host is rated Selective on guests. The Peps Report requires a Pod Score of 80 or higher. The Peps Report's contact route on record: public web form.
The strongest fits for The Peps Report are Health & Wellness Services. The Peps Report has a health audience.
MyPeps hosts The Peps Report, a health podcast with 11 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

Six peps (BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax) reportedly got a yes vote from an FDA advisory panel in July, and some people are treating that as a green light. Mark and Amy walk through why a panel vote is...

Mark and Amy look at cagrilintide, a long-acting version of the fullness hormone amylin, developed mainly to pair with semaglutide as CagriSema. They go through what the phase 2 and phase 3 trials found, how it differs...

This week Mark and Amy dig into KPV, a tiny fragment of the hormone α-MSH, and the lab research on its anti-inflammatory effects in gut cells and mice. They also look at two new 2026 lab papers, how to weigh personal...

GLOW is a premixed vial of BPC-157, TB-500 and GHK-Cu, 70 mg in total, marketed for skin and recovery together. Mark and Amy look at what is actually known. No study has tested the blend itself, so the case for it is...

Episode #8
Mark and Amy walk through the latest MOTS-c research: a mitochondria-derived peptide studied for insulin sensitivity, exercise capacity, heart damage from sepsis, egg-cell energy in aging, and tissue transplants. They...

Mark and Amy break down peptide storage: why freeze-dried powder is the stable form, what oxygen, moisture and light do to a chain of amino acids, and how quickly shelf life drops once water is added. They also cover...

Mark and Amy dig into the 16 research compounds Amino Club just added, from sermorelin and VIP to the Russian "bioregulator" peptides and designer nasal sprays. They sort which have real human data, which rest on one...

Mark and Amy dig into a new JAMA Network Open study that used AI to sort nearly 150,000 Reddit posts about unapproved retatrutide. Users report hunger, fatigue and a racing heart; the TRIUMPH trials found mostly stomach...

Mark and Amy dig into BPC-157, maybe the most talked-about peptide online. There are well over a hundred studies behind it, so why can't you get it at a pharmacy? They walk through the animal research, the five small...

Mark and Amy dig into Semax and Selank, two short peptides developed in Russia and usually given as nasal drops. They're registered medicines there, but not approved in the US, Europe, the UK or Australia. What does the...

Mark and Amy dig into a new review of peptides used in urology and sexual medicine. Out of 76 studies, only two peptides, PT-141 and tesamorelin, have defined dosing and an approved use, and both approvals are narrow...

Mark and Amy dig into a new TRM Labs report: about three in four Chinese chemical vendors it tracked list both peptides and fentanyl precursors, and US buyers send most of the traceable money. They cover what the report...

<p>Australia's anesthesia college says people on GLP-1 injections or other weight-loss peptides should tell their anesthesia doctor before surgery. Nicholas walks through the UK study behind the warning, why...

<p>A blockchain analysis from TRM Labs, published October 6, found that about three in four Chinese chemical vendors it tracked list both peptides and fentanyl precursors, with US buyers sending most of the traceable...

<p>The 2027 WADA Prohibited List takes effect January 1. Nicholas covers the new S0 wording that names "peptides" in general, why BPC-157 and TB-500 stay banned, why GLP-1 drugs are still permitted but monitored, and...

<p>Federal agencies are investigating illnesses tied to injectable glutathione made with an ingredient labeled "dietary supplement grade." Brock walks through the recalls, what the FDA and CDC have said so far, and a...

<p>A reported HHS stopgap could open a path for compounding pharmacies to dispense some peptides that aren't FDA-approved, while formal rules are written. Brock walks through what's confirmed (the July advisory vote)...

<p>Weight-loss drugs went from about 15% to as much as 28% average weight loss in a few years. Nicholas walks through retatrutide, tirzepatide, semaglutide and CagriSema, plus the caveats.</p> <p>Read the full post: New...

<p>Nicholas covers all four phase 3 TRIUMPH trials of Eli Lilly's triple-hormone drug, why cross-trial comparisons mislead, the new skin side effect, and the filing timeline.</p> <p>Read the full post: Retatrutide's...

<p>Nicholas walks line by line through a peptide certificate of analysis: lot numbers, HPLC purity, identity testing, net peptide content, endotoxin, sterility, ISO 17025 labs and red flags.</p> <p>Read the full post...
PitchCentric classifies The Peps Report under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.

The Peptide Research Podcast

Peptides With Michele

The Peptide Podcast

Peptides Explained

Weekly Pep Talk

Peptide of the Week | Weight Loss, Health & Wellness
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ